CFDE Data Portal | Search SLC4A8

	Label	Description
	SLC4A8 Gene (Entity type)	ENSG00000050438 - solute carrier family 4 member 8
	SLC4A8 associations Collection (Entity type)	Associations for SLC4A8_associations
	SLC4A8 associations.tsv File (Entity type)	A file from IDG as part of the Harmonizome project
	SLC4A8-AS1 Gene (Entity type)	ENSG00000271065 - SLC4A8 antisense RNA 1
	GSE233679 14 V 13 NICOTINAMIDE HUMAN DN Gene Set (Entity type)	A Gene Set from LINCS
	GSE114883 romidepsin T cell 1 v 2 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE172016 2 V 5 PACLITAXEL HUMAN UP Gene Set (Entity type)	A Gene Set from LINCS
	GSE228727 2 V 1 DAPAGLIFLOZIN MOUSE UP Gene Set (Entity type)	A Gene Set from LINCS
	GSE102467 3 V 2 PAZOPANIB HUMAN UP Gene Set (Entity type)	A Gene Set from LINCS
	GSE265788 IDH1 inhibition RNA-Directed DNA Polymerase 7 v 5 human dn Gene Set (Entity type)	A Gene Set from LINCS

SLC4A8

ENSG00000050438 - solute carrier family 4 member 8

SLC4A8 associations

Associations for SLC4A8_associations

SLC4A8 associations.tsv

A file from IDG as part of the Harmonizome project

SLC4A8-AS1

ENSG00000271065 - SLC4A8 antisense RNA 1

GSE233679 14 V 13 NICOTINAMIDE HUMAN DN

A Gene Set from LINCS

GSE114883 romidepsin T cell 1 v 2 human up

A Gene Set from LINCS

GSE172016 2 V 5 PACLITAXEL HUMAN UP

A Gene Set from LINCS

GSE228727 2 V 1 DAPAGLIFLOZIN MOUSE UP

A Gene Set from LINCS

GSE102467 3 V 2 PAZOPANIB HUMAN UP

A Gene Set from LINCS

GSE265788 IDH1 inhibition RNA-Directed DNA Polymerase 7 v 5 human dn

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.